12Streptococcus suis (S. suis) is an encapsulated zoonotic pathogen, which is responsible for 13 bacterial meningitis and streptococcal toxic shock-like syndrome (STSLS). Despite many 14 attempts to develop an effective vaccine, none is currently available. Here, a capsular 15 polysaccharide (CPS)-expressing attenuated mutant 2015033 was constructed by deleting 16 five virulence-associated factors (sly, scpA, ssnA, fhb, and ssads) in an outbreak S. suis strain 17 SC19. Genes mentioned above are associated with either innate immunity-evading or tissue 18 barrier-invading. Deletion of these genes did not impact the growth ability and CPS 19 generation of 2015033, and the mutant exhibited no hemolytic activity to erythrocytes and no 20 cytotoxicity to different epithelial or endothelial cells. In addition, 2015033 was more easily 21 2 eliminated by whole human blood in vitro and by mouse blood in vivo. In addition, 2015033 22 showed a diminished invasive ability in different mouse organs (brain, lung, and liver) and 23 avirulent properties in mice associated with weak inflammation-inducing ability.
24Immunization with 2015033 triggered T cell-dependent immunity and this immunity 25 suppressed STSLS during SC19 infection by inhibiting excessive proinflammatory responses.
26In addition, immunization with 2015033 successfully conferred sequence type 27 (STs)-independent protection to mice during heterogeneous infections (ST1, ST7, and ST658).
28This study presents the feasibility of the strategy of multi-gene deletion for the development 29 of promising live vaccines against invasive encapsulated pathogens. 30 IMPORTANCE 31 S. suis is a traditional zoonotic agent causing human meningitis and STSLS, which is also a 32 neglected emerging food-borne pathogen. Increasing antimicrobial resistance invokes 33 reduction of preventative use of antibiotics in livestock creating an urgent need for effective 34 vaccines. Given the expression of CPS is the basis for promising vaccines against 35 encapsulated pathogens, and in order to find an effective and economical strategy for 36 CPS-based vaccine development, multi-gene deletion was introduced into the design of a S. 37 suis vaccine for the first time. From our results, CPS-expressing attenuated mutant 2015033 38 exhibited diminished evasive ability against the innate immune system and reduced invasive 39 properties against different host barriers. To our knowledge, 2015033 is the first 40 STSLS-suppressing S. suis vaccine to provide STs-independent protection during 41 heterogeneous infections.
42Streptococcus suis (S. suis) is an important zoonotic pathogen with considerably high 44 phenotypic heterogeneity, which can be classified into 33 serotypes based on the antigenicity 45 of their capsular polysaccharides (CPS) (1) and 1003 sequence types (STs) according to the 46 sequence of seven house-keeping genes (cpn60, dpr, recA, aroA, thrA, gki, and mutS) (2). As 47 the most virulent serotype, S. suis serotype 2 (S. suis 2) has caused a wide variety of diseases 48 in pigs, incl...